Technology Opportunities

Ariel (8)
BGN (224)
BioRap (13)
BIRAD (26)
Carmel (33)
Hadasit (41)
Mor (22)
Ramot (287)
TASMC (1)
Technion (251)
Tel Hashomer (27)
Yissum (337)
Refine / Revise Search1270 technologies found
page 40 of 64
Novel Bile Acid Conjugates for Treatment of NAFLD/NASH and Obesity (Yissum)
Categories Fatty liver, metabolic syndrome, obesity Development Stage Drug at preclinical stage Patent Status U.S. Provisional Patent Application No. 61/921,558 Market Size 6 million Americans with NASH, and more than 25 million expected by 2025, 90 million suffering ...
Scientific Contact: Oren Tirosh
More Details...
Novel Biofilters to Reduce Nitrate Levels (Yissum)
New approach to water treatment Category Cleantech, Environment, Water Technologies, Biofiltration Development Stage Technology demonstrated in aquariums of up to 200 liters where nitrate accumulation was successfully controlled Patent Status U.S. patent granted (no. ...
Scientific Contact: Amos Nussinovitch
More Details...
Novel Biofilters to Reduce Nitrate Levels in Aquariums (Yissum)
For aquarium water treatment Category Environment, Water Technologies, Biofiltration, Aquarium Filtration Development Stage Pilot studies successfully carried out in commercial-size aquariums Patent Status U.S. patent granted (no. 6,297,033), Israeli patent granted (no. ...
Scientific Contact: Amos Nussinovitch
More Details...
Novel Biomarker for Schizophrenia (Ramot)
Novel Biomarkers for Schizophrenia RNA editing is thought to be a major contributor to brain development and function [1]. A-to-I RNA editing is an enzymatic conversion of genomically encoded Adenosine to Inosine that is recognized as Guanosine by the cellular translational machinery. Such RNA ...
Scientific Contact: Daniel OFFEN
More Details...
Novel carbamoylphosphonates regulating tumor microenvironment (Yissum)
Self targeting to the extracellular fluid gives ideal drugs Categories Cancer, metastasis, drug, zinc enzyme inhibitor Development Stage Drug at preclinical stage Patent Status PCT published (WO2010/089752) Market Size Global oncology drug sales are projected to reach ...
Scientific Contact: Eli Breuer
More Details...
Novel Class of Turn-ON Near-Infrared Probes for Diagnosis and Imaging of Inflammation and Cancer (Ramot)
Complete tumor removal during surgery has a great impact on patient survival. To that end, the surgeon should detect the tumor, remove it and validate that there are no residual cancer cells left behind. Residual cells at the incision margin of the tissue removed during surgery are associated ...
Scientific Contact: Ronit SATCHI-FAINARO
More Details...
NOVEL COHERENT FLUORESCENCE SUPER-RESOLUTION MICROSCOPY (BIRAD)
The ProblemThe localization precision which is limited by the square root of N is obtained due to non-coherent addition of the collected photons. An increase in the precision is required as it leads to significant increase in the imaging resolution for the same amount of illumination of ...
Scientific Contact: Zeev Zalevsky
More Details...
Novel Composition for the treatment of Multiple Myeloma (Tel Hashomer)
Novel Composition for the treatment of Multiple Myeloma Dr Merav Laibo , Sheba Medical Center Categories Novel Drug , Multiple Sclerosis Development Stage Preclinical Patent Status Three related patent applications(2011, 2013, 2014) Background and Technology Multiple myeloma ...
More Details...
Novel Compounds for Disrupting Biofilms (Yissum)
Simple heterocycles to inhibit fungi and bacterial biofilm formation Categories Cleantech, Environment, Water Technologies, Biofouling, Biofilm, Food Packaging Development Stage Our technology has been proven to reduce up to 60% biofilm after one coating application on pipes' inner ...
Scientific Contact: Doron Steinberg
More Details...
Novel Compounds for the Treatment of Liver Fibrosis/Cirrhosis (Tel Hashomer)
Novel Compounds for the Treatment of Liver Fibrosis/Cirrhosis Prof. Ziv Ben-Ari and Dr. Michal Safran, Sheba Medical Center Categories Therapeutic Composition , Liver Fibrosis, Fibrosis, drug Development Stage Preclinical Patent Status Pending THM Reference 2016045 ...
More Details...
NOVEL COMPOUNDS TO TREAT ANTIBIOTIC-RESISTANT CLINICAL ISOLATED PATHOGENS (Tel Hashomer)
Novel compounds to treat antibiotic-resistant clinical isolated pathogens Israel Nisan, Noa Tejman Yarden, Yaakov Davidov, Galia Rahav , Sheba Medical Center Categories Antibiotics, composition, drug resistant, infection disaeses, Development Stage Pre-clinical Patent ...
More Details...
Novel coolant for corrosion-protection of magnesium alloy engine parts (Technion)
The trend towards reduced fuel consumption for automobiles has led to an increase in the use of lighter metallic alloys in engines. Aside from weight reduction, magnesium alloys have other advantages such as reduction in materials cost and reduction of manufacturing costs due to a more efficient ...
More Details...
NOVEL DELIVERY VEHICLE FOR CELL TRANSFECTION (BIRAD)
The ProblemNanoparticles can be manufactured with tunable size, shape and surface as well as biological activity. Their role as nanocarriers is well established. While many nanoparticles are stable as an aqueous colloid, ferro fluid, they maintain an insufficient active surface and are limited in ...
Scientific Contact: Jean-Paul Lellouche
More Details...
Novel fluoroquinolone-aminoglycoside hybrid antibiotics (Technion)
Bacterial resistance to antibiotics plays a major role in today’s medical world. A series of new hybrid antibiotics containing fluoroquinolone and aminoglycoside antibiotics were designed, synthesized and their antibacterial activities were determined. This combination yielded a new ...
More Details...
Novel Guide Device for Temporomandibular Joint Arthroscopy (Tel Hashomer)
Novel Guide Device for Temporomandibular Joint Arthroscopy Dr. Waseem A. Abboud, Sheba Medical Center Categories Maxillofacial Surgery, Medical Surgery Guided device Development Stage Preclinical, prototype design Patent Status Pending THM Reference 2015043 Abstract The ...
More Details...
Novel Horizons in Cancer Treatment and Prevention (Carmel)
Identifying novel substances and mechanisms to develop cancer-fighting pharmaceutical drugs. Research with the Cancer-Resistant Subterranean Blind Mole-Rat (Spalax) Prof. Aaron Avivi (standing) with Dr. Imad Shams and Prof. Irena MarinovPhoto credit: Tomer Appelbaum BackgroundUnderstanding the ...
More Details...
Novel Integrase Based Cancer Treatment Technology (Ramot)
We have developed a new gene therapy technology for specific cancer cells killing and validated both efficacy and safety superiority of the proposed system over the conventional one in lung cancer mice model. The proposed system offers advantages over already known counterparts and may ...
Scientific Contact: Mikhail Kolot
More Details...
Novel Ionizable lipids for delivery of nucleic acids (mRNA, DNA, siRNA) (Ramot)
BackgroundChemotherapy treatment is generally accompanied by adverse effects, which can be significantly reduced using site specific, targeted delivery systems, such as antibody-coated LNPs (immuno-LNPs). However due to inter-and intra-tumor heterogeneity targeting with a single targeting ...
Scientific Contact: Dan PEER
More Details...
Novel Laryngoscope for Veterinary Applications (Yissum)
Enables single person to freely intubate, inspect and operate Categories Veterinary, Devices Development Stage Laboratory prototype used in procedures on dogs Patent Status United States patent application filed Market Size Consulting firm Vetnosis reports that the global ...
Scientific Contact: Ana EPSTEIN
More Details...
Novel Macrocyclic Molecules for Treating and Preventing HIV Infection (CG1) (Yissum)
New compounds mimicking CD4 protein, inhibiting gp120/CD4 interaction and the consequent infection of cells by HIV Categories HIV/AIDS, Therapeutic Drug, Preventive Treatment Patent Status US patent application filed Target Market In 2007, HIV drugs achieved global sales of ...
Scientific Contact: Chaim Gilon
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.